<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://harvardscience.harvard.edu" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>all Emily Pierson stories</title>
 <link>http://harvardscience.harvard.edu/stories/person/1804</link>
 <description>Stories and external links referencing a person (RSS)</description>
 <language>en</language>
<item>
 <title>Sublethal force: New antibiotic aims to tame bacterial toxins</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/sublethal-force-new-antibiotic-aims-tame-bacterial-toxins</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;Using an innovative screening approach, researchers in the lab  of John Mekalanos have identified an entirely new class of  antibiotics active against the cholera bacterium. While traditional  antibiotics kill bacteria outright by interfering with processes  essential for their survival, the new agents block production of  bacterial proteins that promote infection and cause cholera  symptoms. Tests in animals proved that the new compounds  could prevent bacterial colonization.
&lt;p&gt;The work opens up a new world of potential for antibacterial  drugs that aim to block the unique disease-causing talents of  cholera bacteria, which include the production of cholera toxin.  &quot;What we&#039;ve done is made a custom, organism-specific  antibiotic against Vibrio cholerae,&quot; said Mekalanos, the Adele  Lehman professor of microbiology and molecular genetics and  head of that department. Since most bacteria that cause human  disease elaborate virulence factors such as toxins, Mekalanos  said, &quot;There is no reason our approach can&#039;t be replicated for a  number of other important pathogens.&quot; The research appeared  Oct. 13, 2005 in the online edition of Science.&lt;/p&gt;
</description>
 <pubDate>Mon, 26 Mar 2007 05:41:29 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3561 at http://harvardscience.harvard.edu</guid>
</item>
</channel>
</rss>
